Conference item icon

Conference item

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
Expand authors...
Volume:
70
Issue:
2
Pages:
298-299
Host title:
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Publication date:
2010-08-01
ISSN:
0306-5251
Source identifiers:
95972
Pubs id:
pubs:95972
UUID:
uuid:c56b4cfe-ebb1-4efd-a512-d21e35a28eff
Local pid:
pubs:95972
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP